To understand the molecular pathways involved in the pathogenesis of squamous cell lung carcinoma, we obtained DNA from 94 microdissected foci from 12 archival surgically resected tumors including histologically normal epithelium (n=13), preneoplastic lesions (n=54), carcinoma is situ (CIS) (n=15) and invasive tumors (n=12). We determined loss of heterozygosity (LOH) at 10 chromosomal regions (3p12, 3p14.2, 3p14.1-21.3, 3p21, 3p22-24, 3p25, 5q22, 9p21, 13q14 RB, and 17p13 TP53) frequently deleted in lung cancer, using 31 polymorphic microsatellite markers, including 24 that spanned the entire 3p arm. Our major ®ndings are as follows: (1) Thirty one percent of histologically normal epithelium and 42% of mildly abnormal (hyperplasia/metaplasia) specimens had clones of cells with allelic loss at one or more regions; (2) There was a progressive increase of the overall LOH frequency within clones with increasing severity of histopathological changes; (3) The earliest and most frequent regions of allelic loss occurred at 3p21, 3p22-24, 3p25 and 9p21; (4) The size of the 3p deletions increased with progressive histologic changes; (5) TP53 allelic loss was present in many histologically advanced lesions (dysplasia and CIS); (6) Analyses of 58 normal and non-invasive foci having any molecular abnormality, indicated that 30 probably arose as independent clonal events, while 28 were potentially of the same clonal origin as the corresponding tumor; (7) Nevertheless, when the allelic losses in the 30 clonally independent lesions and their clonally unrelated tumors were compared the same parental allele was lost in 113 of 125 (90%) of comparisons. The mechanism by which this phenomenon (known as allele speci®c mutations) occurs is unknown; (8) Four patterns of allelic loss in clones were found. Histologically normal or mildly abnormal foci had a negative pattern (no allelic loss) or early pattern of loss while all foci of CIS and invasive tumor had an advanced pattern. However dysplasias demonstrated the entire spectrum of allelic loss patterns, and were the only histologic category having the intermediate pattern. Our ®ndings indicate that multiple, sequentially occurring allele speci®c molecular changes commence in widely dispersed, apparently clonally independent foci, early in the multistage pathogenesis of squamous cell carcinomas of the lung.
Introduction
Lung cancer is the most frequent cause of cancer deaths in both men and women in the USA (Parker et al., 1997) and tobacco smoking is accepted as the major cause of this neoplasm (Parkin et al., 1994) . Lung cancer is classi®ed into two major groups, small cell lung carcinoma (SCLC) and non small cell lung carcinoma (NSCLC) . Squamous cell carcinoma, adenocarcinoma and large cell carcinoma are the major histologic types of NSCLC (Colby et al., 1995) . As with other epithelial malignancies, lung cancers are believed to arise after a series of progressive histopathological changes (preneoplastic lesions) in the bronchial epithelium (Saccomanno et al., 1974) . However, the sequence of histologic changes has been established only for squamous cell carcinoma. The morphologic preneoplastic steps include hyperplasia, squamous metaplasia, dysplasia and carcinoma in situ (CIS) (Saccomanno et al., 1974) . These changes frequently are extensive and multifocal, occurring throughout the respiratory tree, a phenomenon referred to as ®eld cancerization (Strong et al., 1984) .
Many mutations, especially those involving recessive oncogenes, have been described in clinically evident lung cancers . However, relatively little is known about the sequence of molecular events preceding the development of invasive lung carcinoma. Allelic losses at chromosomal regions 3p, 9p and 17p occur relatively early during the multistage development of invasive lung cancer (Chung et al., 1996; Hung et al., 1995; Kishimoto et al., 1995; Sundaresan et al., 1992; Thiberville et al., 1995) . In addition, the occurrence of aneuploidy and microsatellite alterations (MA) is evidence of more generalized genomic instability in lung cancer and its preneoplastic lesions (Mao et al., 1994; Miozzo et al., 1996) . MAs represent changes in the size of simple nucleotide repeat polymorphic microsatellite markers, resulting in altered electrophoretic mobility of one or both alleles. In lung cancers they have been reported to occur at frequencies ranging from 0 ± 45% (Adachi et al., 1995; Fong et al., 1995; Merlo et al., 1994) . Although the mechanisms underlying MAs are currently unknown, they may represent a manifestation of genomic instability (Fishel, 1996) .
Recently, we and others (Mao et al., 1997; Wistuba et al., 1997a) have reported a very high incidence of molecular abnormalities (LOH and MAs) in the normal and abnormal bronchial mucosa of former and current smokers. While 80% of current and former smokers had evidence of clones of cells exhibiting allele loss in their bronchial mucosa, never smoker subjects had no or only rare changes (Wistuba et al., 1997a) . Given this background and to further understand the molecular pathways involved in the pathogenesis of lung cancers, we studied the sequence of molecular abnormalities involved in the pathogenesis of the multistep development of squamous cell lung carcinoma.
Results

Identi®cation of lesions for molecular analyses
We selected 12 cases of squamous cell carcinoma that underwent curative intent lobectomies, and which contained multiple foci of histologically varied preneoplastic changes, examined all available microslides. All of the invasive carcinomas appeared to arise in large, centrally located bronchi. We identi®ed a total of 94 histologically discrete foci each of which contained at least 800 cells. They included samples from the 12 invasive carcinomas, 54 preneoplasias (23 hyperplastic, 10 metaplastic, 21 dysplastic lesions), 15 carcinomas in situ (CIS) and 13 samples of histologically normal epithelium ( Figure 1a) . One or more foci of hyperplasia/squamous metaplasia and dysplasia were present in all 12 cases, one or more discrete carcinoma in situ lesions were identi®ed in ten cases and a sample of histologically normal epithelium was taken from each case. Five of the histologically normal and ®ve of the preneoplastic lesions were identi®ed in bronchioles, while the remainder (n=54) were present in centrally located large bronchi (lobar, segmental and subsegmental). All of the CIS lesions were located in large bronchi.
Allelic loss in histologically normal and abnormal epithelium accompanying tumors
We detected allelic loss at one or more regions in four (31%) of 13 foci of histologically normal epithelium. However, the mean FRL (Fractional Regional Loss) index was relatively low (0.07). Increasing severity of histologic change was characterized by a rise in both of these parameters (Figures 2a,b and 3 ). Thus 81% of dysplastic lesions and 100% of CIS and invasive tumors demonstrated allelic loss, with relatively high mean FRL indices. However, the dierences between histologically normal and mildly abnormal epithelium were modest and not signi®cant. Thus, for some analyses ( Figure 5 ) we combined the data from these two morphologic categories.
Similar frequencies of LOH were detected in epithelial samples obtained from centrally located bronchial epithelium (43 of 72, 60%) and from peripheral bronchioles (7 of 10, 70%). There was no 
Frequencies of LOH at individual chromosomal regions
Allelic loss was not random, and loss at one or more 3p regions and at 9p were the only losses noted in histologically normal epithelium (Figure 2a ). Occasional loss (7%) at the TP53 gene was noted in mildly abnormal epithelium (Figure 2a ) but was more frequent in dysplasia (37%) and CIS (75%). Losses at the RB gene at a 5q (APC-MCC region) commenced at the dysplasia stage. The dierences between CIS and invasive carcinomas were modest and not signi®cant.
Sequential 3p deletions were detected in the pathogenesis of squamous cell lung carcinoma Because we used 24 microsatellite markers spanning six contiguous chromosome 3p regions, we could compare the size of the deletions in histologically normal, preneoplastic, CIS and tumor foci. In all invasive cancers and CIS lesions most of the 3p arm was deleted ( Figure 4 ). In all 12 individual cases the extent of the losses in CIS (3p FAL index of 0.74) and invasive carcinomas (3p FAL index of 0.81) were greater than in the corresponding normal and preneoplastic foci ( Figure 4 ). As demonstrated in Figure 4 , the extent of the 3p deletions in histologically normal and mildly abnormal foci were signi®cantly (mean 3p FAL index of 0.05; P50.0001) smaller and more discrete than in the more advanced foci (CIS and invasive carcinoma), while the losses in dysplastic lesions were intermediate (mean 3p FAL index of 0.22).
In normal and mildly abnormal epithelial foci the 3p losses were not random. Losses at 3p21, 3p22-24 and 3p25 were detected in histologically normal epithelium, while losses at 3p14.2 and 3p14-21 commenced at the stage of hyperplasia/metaplasia. Allelic loss at 3p12 region was ®rst detected at the later stage of dysplasia ( Figure 2b ).
Patterns of allelic loss
To determine the sequential molecular changes involved in the development of squamous cell lung carcinoma, we analysed the pattern of deletions detected in the invasive tumors and their accompanying normal and abnormal epithelial lesions. As nine lung cancers and their 64 corresponding epithelial specimens were informative for 9p21, TP53 and all six 3p regions, only deletions at those eight chromosomal regions were considered. Four patterns of allelic loss, were discerned in the 73 normal, preneoplastic and neoplastic foci ( The relationship between histologic diagnoses and patterns of allelic loss are displayed in Figure 5b . Of interest, histologically normal and mildly abnormal foci had A (negative) or B (early) patterns, while CIS and invasive carcinomas always had D (advanced) pattern. In contrast, dysplastic lesions demonstrated the entire spectrum of patterns, and were the only histologic category having the C (intermediate) pattern.
Microsatellite alterations in tumors and accompanying histologically normal and abnormal epithelium
We found MAs at one or more chromosomal loci in one of 13 (8%) of histologically normal foci, in four of 54 (7%) preneoplastic foci, in two of 15 (13%) CIS foci and in six of 12 (50%) invasive carcinomas. None of the MAs detected in normal or abnormal epithelia were identical to the alterations observed in the corresponding invasive tumors.
Potential clonal relationship of epithelial foci
One or more molecular changes (allelic loss or microsatellite alteration) were detected in 62 (66%) of 94 histologically normal, preneoplastic or neoplastic foci examined. We used these changes (including presence of allelic loss, the speci®c allele lost and the presence and type of microsatellite alteration) to determine whether the foci in individual cases were clonally related. Identical molecular changes were present in only four (6%) foci (two hyperplastic lesions from one patient and two non-contiguous foci of CIS in another patient). Of the remaining 58 foci, possible evidence of a clonal relationship (through sequential changes) were present in 28 (48%). In the other 30, the patterns of molecular changes suggested that they arose as independent clones (or possibly as subclones from a precursor clone having some initial molecular change for which we did not examine). In Figure 6 we illustrate the analysis of foci from a representative case.
Allele speci®c mutations (ASM)
Previous studies of dierent bronchial lesions from the same individual patient demonstrated that at any one locus, loss of parental alleles was not random, and that there was a strong tendency for the identical allele to be lost in all non-neoplastic and neoplastic foci examined (Hung et al., 1995; Kishimoto et al., 1995; Sundaresan et al., 1992; Wistuba et al., 1995) (Figure  1 ). We refer to this phenomenon as allele speci®c mutations (ASM) (Hung et al., 1995; Kishimoto et al., 1995; Sundaresan et al., 1992; Wistuba et al., 1995) . We determined the frequencies of ASM in the 69 foci demonstrating one or more sites of allelic loss in all 12 patients. For all 297 comparisons involving ten chromosomal regions, the same parental allele was lost in 286 (96%). The possibility of this happening by chance are extremely remote as tested by the cumulative binomial test (P=1.3610 770 ). Similar frequencies of ASM were present when only the apparently clonally unrelated foci were examined (165 of 183 comparisons, 90%; P=2.8610
731
).
Discussion
Our current ®ndings con®rm and greatly extend the previous observations of ours and others that mutations accumulate early in the multistage pathogenesis in smoking damaged epithelium (Mao et al., 1997; Wistuba et al., 1997a) . We limited the present study to the pathogenesis of squamous carcinoma arising in the setting of smoking damaged respiratory epithelium because the sequence of histologic changes in this cancer is well established. In contrast the preneoplastic changes preceding the other major forms of lung cancer are either unknown (small cell carcinoma) or only suspected (peripheral adenocarcinomas) (Colby et al., 1995) .
Molecular changes preceded the onset of histologically recognizable changes. Thirty one percent of histologically normal foci had allelic loss at one or more chromosomal regions. This ®gure is slightly lower than our previously reported study in heavy smokers Only dysplastic lesions demonstrated the entire spectrum of patterns, and was the only histologic category having the intemediate pattern Figure 6 Representative example of clonal analyses of lesions present in the lobectomy specimen of a case of lung squamous cell carcinoma. Dysplastic lesion D1 (arrow), which contains a single site of allelic loss (marker D3S1244) may be the precursor lesion of dysplastic foci D2 as well as CIS lesion (C1) and the invasive tumor (T1). All of the latter three lesions have lost at D3S1244, but each of them also have other distinctive allelic losses, indicating that they must have evolved along independent subclonal pathways. However, hyperplastic lesions H1, H2 and H3 have a pattern of molecular changes not present in any of the other preneoplastic or neoplastic foci, suggesting that they arose as independent clones. &, No LOH;
, Upper allele lost; , Lower allele lost (Wistuba et al., 1997a) . In the latter study,¯uorescence bronchoscopy was used to select biopsy sites (from areas of abnormal¯uorescence), possibly accounting for the higher mutational frequency. In addition, the biopsies obtained by ®beroptic bronchoscopy are relatively small and have limited numbers of epithelial cells. In surgically resected samples, extensive areas of normal epithelium were frequently present, and the relatively large microdissected foci may have contained more than one clonal or subclonal populations. Allelic losses have also been described in histologically normal epithelium adjacent to or near breast and gallbladder carcinomas (Deng et al., 1996; Wistuba et al., 1995) .
There was a progressive increase of the overall LOH frequency with increasing severity of histopathological changes. The development of epithelial cancers requires multiple mutations (Fisher, 1958) , the stepwise accumulation of which may represent a mutator phenotype (Loeb, 1991 (Loeb, , 1994 . Thus, it is possible that those preneoplastic lesions that have accumulated multiple mutations are at higher risk for progression to invasive cancer. Similar incidences of LOH were detected between histologically normal epithelium and mildly abnormal epithelial changes (hyperplasia and squamous metaplasia) suggesting that these morphological changes do not predict for higher risk of progression. However dysplasias and CIS demonstrated a signi®cant increased overall incidence of LOH, suggesting that the accumulation of mutations correlates with the morphologic changes in these more advanced lesions and that they may be more likely to progress to invasive carcinoma (sequential theory of lung cancer development). In particular, the allelic loss pattern of CIS lesions were identical or nearly identical to those present in the corresponding invasive carcinomas.
Alterations in microsatellite size (microsatellite alterations) are present in many cancers, including lung carcinomas (Adachi et al., 1995; Fong et al., 1995; Mao et al., 1994; Merlo et al., 1994) and may re¯ect a form of genomic instability (Wistuba et al., 1998) . We found MAs in 50% of the invasive tumors and in lesser percentages of histologically normal, preneoplastic and CIS foci. Unlike allelic losses, the frequency of MAs did not increase with more advanced histologic changes. We have previously reported similar ®ndings in smoking damaged epithelium (Wistuba et al., 1997a) . Of interest, MAs, when present in nonmalignant foci, were always of a dierent size than those present in the corresponding invasive tumors. These ®ndings indicate that either the preneoplastic lesions are not clonally related to the corresponding tumors, or that the MAs arose during subclonal evolution. The ®nding of MAs in exfoliated cells present in sputum (Miozzo et al., 1996) from patients suggest that they may be markers for lung cancer or those at increased risk of developing lung cancer. While the MAs present in preneoplastic lesions were not present in the corresponding tumors, the presence of MAs may still predict for increased risk, as they probably represent a form of genomic instability (Loeb, 1994) .
Allelic losses present in preneoplastic lesions were not random. The earliest and most frequent regions of allelic loss occurred at 3p21, 3p22-24, 3p25 and 9p21. Losses at other 3p regions (3p12, 3p14.2, 3p14 ± 21) and the TP53 gene were present mainly in histologically advanced lesions (dysplasia and CIS). Of interest, 3p deletions have been described as early events during the multistage pathogenesis of several other epithelial cancers including head and neck, cervix and breast (Deng et al., 1996; Wistuba et al., 1997b) . In contrast, deletions at chromosome 5q and 13q (near the APC and at RB genes) were mainly associated with invasive carcinomas, and were relatively rare in precursor lesions. These observations have to be interpreted with the caveat that our studies focused on chromosome 3p which was analysed with the use of 24 polymorphic markers while only seven markers were used to study the other four regions studied.
Based on these ®ndings, the size of the 3p deletions increased with progressive histologic changes. The short arm of chromosome 3 (3p) contains several discrete regions, including 3p12, 3p14, 3p21 and 3p24 ± 25, which are deleted in lung and other cancers, and which are believed to harbor several recessive oncogenes . Progressive deletions in 3p from dysplasia to invasive lung carcinoma have been reported in three cases using 11 chromosome 3p markers (Chung et al., 1995) . Because we used 24 microsatellite markers spanning six contiguous chromosome 3p regions, we could better compare the size of the deletions in histologically normal, preneoplastic and neoplastic foci. In all invasive cancers and CIS lesions most of the 3p arm was deleted, and in all 12 patients the extent of the losses in CIS and invasive carcinomas was greater than the 3p allele loss found in the corresponding normal and preneoplastic foci. Recent attention has focused on the FHIT at 3p14.2, a candidate tumor suppressor gene for lung and other cancers, which spans FRA3B, the most common of the aphidocolin-inducible fragile sites Ohta et al., 1996; Sozzi et al., 1996) . While it is tempting to speculate that breaks at FRA3B destabilize the entire short arm of chromosome 3, leading to multiple deletions, allelic losses at other more telomeric 3p regions appeared at histologically earlier stages than losses within and around the FHIT gene.
Molecular analyses suggested that precursor lesions represented outgrowths of multiple clones, a ®nding compatible with the ®eld eect theory (Strong et al., 1984) . Of 58 normal and non-invasive foci having any molecular abnormality, 30 probably arose as independent clonal events, while 28 were potentially of the same clonal origin as the corresponding tumor. If the potentially clonal lesions are truly clonal in origin, subclonal drift (Nowell, 1976) must have occurred as an early and widespread event, as only four foci (6%) (from two subjects) of 62 lesions had identical patterns of mutations. However, we cannot exclude the possibility that some other earlier molecular event (which we did not examine) occurred in a single cell whose progeny were dispersed widely throughout the bronchial epithelium and subsequently gave rise to all of the foci we examined. If this event occurred, then subclonal drift (Nowell, 1976) must have occurred as an early and widespread event.
Of interest, the same parental allele was almost always lost (96% of comparisons) in non neoplastic lesions as in the corresponding invasive carcinomas. We and others have documented this phenomenon (allele speci®c mutations, ASM) previously both in the respiratory epithelium of smokers and in patients with lung cancer (Hung et al., 1995; Kishimoto et al., 1995; Sundaresan et al., 1992; Wistuba et al., 1995) . The mechanism by which this phenomenon occurs is unknown. We have proposed two possibilities for ASM (Hung et al., 1995) : (a) a single cell or small clone of cells develops loss at a speci®c parental allele of one or more polymorphic loci, migrates widely throughout the respiratory epithelium of lung and gives rise to multiple foci of abnormal epithelium; or (b) in individuals, one of any pair of alleles has a greater tendency to be lost, perhaps as a result of some form of genomic imprinting or the presence of fragile sites. The ®nding of a single point mutation in the TP53 gene widely dispersed in the respiratory epithelium of a smoker (Franklin et al., 1997) would favor the clonal theory. However, ASMs were noted even in non neoplastic lesions that appeared to be of independent clonal origin, suggesting that ASMs occur via an alternative mechanism. Whatever the mechanism, ASM is likely to be a phenomenon of major biological signi®cance.
Based on our ®ndings, four patterns of allelic loss could be determined: A (negative), B (early), C (intermediate) and D (advanced). Histologically normal or mildly abnormal foci had a negative pattern (no allelic loss) or early pattern of loss while all foci of CIS and invasive tumor had an advanced pattern. Because of their relatively small numbers, we did not subdivide dysplasias into mild, moderate and severe categories. However, dysplasias demonstrated the entire spectrum of allelic loss patterns, and were the only histologic category having the intermediate pattern. These ®ndings suggest that dysplasias represent a heterogeneous group of lesions at a molecular level. As only a fraction (10% of moderate dysplasia, 40 ± 80% of severe dysplasias) are believed to progress to cancer (Band et al., 1986; Frost et al., 1986; Risse et al., 1988) molecular studies may aid in the identi®cation of the subgroups of smokers with dysplasia who are at the greatest risk of progression to lung cancer.
Our ®ndings indicate that multiple, sequentially occurring, allele speci®c molecular changes commence in widely dispersed, apparently clonally independent foci early in the multistage pathogenesis of squamous cell carcinomas of the lung. Clinical studies underway are exploring whether molecular changes in smoking damaged epithelium can be utilized for risk assessment and for monitoring the ecacy of chemopreventive regimens.
Materials and methods
Tumor specimens and patient information
Archival surgically resected squamous cell carcinomas of lung were examined for the presence of histologically normal epithelium and preneoplastic lesions, and 12 paran-embedded squamous cell carcinomas of the lung specimens (six pulmonectomies and six lobectomies) containing multiple foci of CIS and preneoplastic lesions were selected for study and a chart review for clinical information performed. The post surgical clinicopathologic stage was determined by standard criteria, and 11 were stage I, one stage II. The patients (one woman and 11 men) ranged in age from 55 to 75 years (median 57). All the patients were smokers (median 40 pack-years), and most of them heavy smokers (range 15 to 120 pack-years).
Serial 5 m-sections were cut from archival, formalin-®xed, paran-embedded tissue. All slides were stained with hematoxylin-eosin, and one of the slides was cover slipped. The cover slipped slide was used as a guide to localize regions of interest for microdissection of the other slides.
Identi®cation of histologically normal epithelium and preneoplastic lesions
All compartments of the respiratory tree (centrally located lobar, segmental and subsegmental bronchi, peripheral bronchioles and alveoli) were examined. The microslides were examined by two pathologists (AFG and IIW) and scored using published criteria for the histologic identification of epithelial preneoplastic lesions of lung (Saccomanno et al., 1974) . Histopathologic diagnoses were categorized as: (1) Normal respiratory epithelium; (2) Hyperplasia (goblet cell or basal cell type), or simple squamous metaplasia without dysplasia. We use the term mildly abnormal epithelia' for this histologic category; (3) Dysplasia. Because of limited numbers, we did not divide dysplasias into mild, moderate and severe categories; (4) Carcinoma in situ (CIS) (Figure 1a ). Although minor atypical changes arising in hyperplastic respiratory epithelium were identi®ed, only widely recognized preneoplastic lesions arising in epithelium with squamous metaplasia were categorized as dysplastic changes. All nonmalignant lesions, including hyperplasia, squamous metaplasia and dysplasia, were referred to as`preneoplasia'. We used the term`non-invasive' for preneoplasias and CIS lesions.
Microdissection and DNA extraction
We examined all identi®able preneoplastic lesions, CIS foci and regions of normal respiratory epithelium accompanying the invasive carcinomas that contained sucient cells (500 ± 800 cells) for molecular analyses. Microdissection and DNA extraction were performed as previously described from multiple sections (microslides) of each sample (Hung et al., 1995) . Precisely identi®ed areas of normal and abnormal respiratory epithelium were microdissected under microscope visualization. Dissected lymphocytes and stromal cells were used as a source of constitutional DNA from each case. After DNA extraction, ®ve ml of the proteinase K digested samples, containing DNA from at least 100 cells, were used for each multiplex PCR reaction.
Polymorphic DNA markers and PCR-LOH analysis
To evaluate LOH and MAs, we used primers¯anking 31 dinucleotide and multinucleotide microsatellite repeat polymorphisms located at the following ten genes or chromosomal regions: 3p12 (D3S1511, D3S1577, D3S1284 and D3S1274), 3p14.2 (D3S1300, D3S4103 and D3S1234 at the FHIT gene), 3p14.1-21.3 (D3S1766), 3p21 (D3S1447, ITIH-1, D3S1573, K1.CA, D3S1478, D3S1029), 3p22-24.2 (D3S1582, D3S1612, D3S2432, D3S1351, D3S1537, D3S1244), 3p25 (D3S1293, D3S1597, D3S1111, D3S1110), 5q22 (L5.71 in the APC-MCC region), 9p21 (D9S171, IFNA, D9S1748), 13q14 (dinucleotide repeat at the RB gene) and 17p13 (TP53 dinucleotide and pentanucleotide repeats). Primer sequences can be obtained from the Genome Database, with ®ve exceptions: ITIH-1 (Thiberville et al., 1995) , pentanucleotide (Cawkwell et al., 1994) and dinucleotide (Jones and Nakamura, 1992) repeats in the TP53 gene, dinucleotide repeat in the RB gene (Toguchida et al., 1993) , and the K1.CA dinucleotide marker identi®ed in our laboratory (forward primer 5'-CATCCTCTCACCATGTACAG-3; reverse primer 5'-CAAGGGGACAGAGACTTTG-3').
Nested PCR or two-round PCR (using the same set of primers in two consecutive ampli®cations) methods were used. Multiplex PCR was performed during the ®rst ampli®cation, followed by uniplex PCR for individual markers. In the multiplex PCR, six markers were ampli®ed during the same reaction. Volumes of 50 ml were used for each multiplex reaction, containing 20 mM Tris (pH 8.3), 50 mM KCl, 2.5 mM MgCl 2 400 mM of each deoxynucleotide triphosphate (dATP, dCTP, dGTP, dTTP), 0.5 mM of each forward and reverse primer, and 3.5 units of AmpliTaq Gold (Perkin Elmer, Foster City, CA, USA) (Birch, 1996) . The ®rst PCR product was diltued 1 : 10 in double distilled sterile water and used for the second PCR reaction, which was performed in a 10 ml reaction volume containing 20 mM Tris (pH 8.3), 50 mM KCl, 1.5 mM MgCl 2 , 100 mM of each deoxynucleotide triphosphate (dATP, dCTP, dGTP, dTTP), 0.5 mM of forward and reverse primer, 0.25 unit of AmpliTaq polymerase (GIBCO-BRL, Alameda, CA, USA), 0.25 ml of [a-32 P]dCTP (3000 Ci/mol, 10 mCi/ml Amersham LIFE SCIENCE, Arlington Heights, IL, USA), and 1 ± 2 ml of diluted ®rst PCR product. For both PCR reactions, a`touch-down' PCR (Don et al., 1991) was performed. After initial denaturation of 948C for 4 ± 8 min, 11 cycles each consisting of denaturation at 958C for 20 s, annealing at 65 to 568C for 55 s and extension at 728C for 20 s were performed, followed by additional 24 cycles which included denaturation at 908C for 20 s, annealing at 558C for 20 s and extension at 728C for 20 s. Then, a 5 ml aliquot of each second PCR reaction was diluted 1 : 4 with loading buer, heat denatured, and separated by electrophoresis on a denaturing 6% polyacrylamide gel containing urea as published (Hung et al., 1995) . LOH was scored by visual detection of complete absence of one allele (Figure 1b) , and MAs were detected by a shift in the mobility of one or both alleles.
Data analysis
We utilized multiple polymorphic markers (n=31) to examine for LOH at ten chromosomal regions located on ®ve chromosomal arms. For data analysis, we used three approaches: (1) For individual foci we determined the frequencies of LOH at individual chromosomal regions; (2) To determine whether the deletions in chromosome 3p were progressive in individual foci, we determined frequencies of loss of individual markers using a Fractional Allelic Loss Index as de®ned below:
3p Fractional Allelic Loss (FAL) index= total number of chromosome 3p markers with LOH total number of informative 3p markers (3) The FAL index was originally used de®ned by Vogelstein et al. (1989) as a measure of genome wide loss. However, in their original study, only one marker was used per chromosomal arm. As we used multiple markers for eight of the ten chromosomal regions we studied, we substituted a Fractional Regional Loss index, as de®ned below, as a measure for overall allelic loss:
Fractional Regional Loss (FRL) index= total number of chromosomal regions with LOH total number of informative regions
To correlate morphological changes with allelic loss, we calculated the mean FRL Index for each histologic category. Statistical analysis was performed using the non-parametric Wilcoxon test. The cumulative binomial test (Siegel, 1956 ) was used to examine the likelihood that the occurrence of a particular event (loss of the same allele in the invasive carcinoma and an associated epithelial sample) occurs at a particular probability when observed in repeated trials. When the results are compared with a chance occurrence or nonoccurrence, the particular probability of comparison is 0.5. Probability values of P50.05 were regarded as statistically signi®cant.
